Clinic
Farouk A. Raquib, M.D., P.C.
Farouk A. Raquib, M.D., P.C. was paid $6.24M by Medicaid between Jan 2018 and Dec 2024, across 80 billing codes. Its largest line is 87633, Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets — 24% of everything it billed.
33Billing provider infoFAROUK A. RAQUIB, M.D., P.C.
WINFIELD, AL 35594
WINFIELD, AL 35594
33aNPI1760531479assigned 01/10/2007
33bProvider typePrimary Care Clinic/Center
28Total paid$6.24M
24GClaims243,902
24DCodes billed80
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Primary Care Clinic/Center providers in Alabama
Rank by total paid#2 of 75
Median peer was paid$56K
This provider vs. median111×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 14,263 | $112K | |
| 2019 | 17,838 | $197K | |
| 2020 | 27,060 | $697K | |
| 2021 | 50,885 | $1.51M | |
| 2022 | 60,711 | $1.93M | |
| 2023 | 43,551 | $952K | |
| 2024incomplete | 29,594 | $837K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 24% | 8,409 | 7,596 | $1.47M |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 19% | 6,994 | 6,027 | $1.20M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 13% | 20,630 | 16,148 | $797K |
| 87634 | 5.0% | 8,447 | 7,648 | $313K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 5.0% | 8,043 | 7,222 | $312K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 3.4% | 4,470 | 4,063 | $211K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 3.3% | 9,595 | 8,606 | $206K |
| 87581 | 3.2% | 9,467 | 8,291 | $200K | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 3.1% | 3,115 | 2,481 | $196K |
| 87486 | 3.0% | 8,869 | 7,724 | $185K | |
| 87640 | 2.8% | 9,729 | 8,807 | $175K | |
| 87541 | 2.5% | 7,450 | 6,540 | $158K |
68 more codes
| 87498 | 2.4% | 8,750 | $150K | |
| 99214 | Doctor's office visit, returning patient (more involved) | 2.1% | 3,525 | $129K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.8% | 3,224 | $110K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 1.3% | 1,696 | $81K |
| 87641 | <1% | 3,710 | $57K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 2,970 | $54K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 4,228 | $44K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 3,023 | $44K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 8,172 | $41K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 6,292 | $40K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,334 | $23K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,353 | $17K |
| 80053 | Comprehensive metabolic panel | <1% | 1,169 | $7K |
| 80061 | Lipid panel | <1% | 542 | $3K |
| 90674 | <1% | 329 | $2K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 116 | $2K |
| 80051 | <1% | 603 | $1K | |
| 81003 | <1% | 716 | $1K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 116 | $1K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 3,366 | $1K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 325 | $1K |
| 84460 | <1% | 211 | $707.00 | |
| 82977 | <1% | 190 | $665.00 | |
| 84075 | <1% | 212 | $606.00 | |
| 84450 | <1% | 211 | $606.00 | |
| 82565 | <1% | 212 | $606.00 | |
| 82247 | <1% | 236 | $545.00 | |
| 82040 | <1% | 225 | $540.00 | |
| 84520 | <1% | 212 | $505.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 56 | $464.00 |
| 82947 | <1% | 223 | $424.00 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 525 | $391.67 |
| 84155 | <1% | 212 | $364.61 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 176 | $325.00 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 206 | $307.84 |
| 84439 | <1% | 65 | $297.00 | |
| 87807 | <1% | 40 | $275.00 | |
| 87999 | <1% | 1,853 | $270.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 3,156 | $252.37 |
| 90714 | <1% | 36 | $211.60 | |
| 94060 | <1% | 14 | $160.47 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 37 | $156.00 |
| 99051 | <1% | 748 | $136.42 | |
| 80305 | <1% | 33 | $136.11 | |
| 93000 | <1% | 17 | $135.80 | |
| 86318 | <1% | 39 | $117.00 | |
| 84153 | <1% | 17 | $100.00 | |
| 72100 | <1% | 14 | $95.40 | |
| 84703 | <1% | 16 | $72.00 | |
| 86308 | <1% | 15 | $60.53 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 18 | $5.82 |
| 36415 | Collection of venous blood by venipuncture | <1% | 6,380 | $2.00 |
| 3074F | 0% | 10,131 | $0.00 | |
| 3079F | 0% | 2,064 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 6,472 | $0.00 |
| G8418 | Bmi is documented below normal parameters and a follow-up plan is documented | 0% | 898 | $0.00 |
| 3075F | 0% | 1,110 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 208 | $0.00 |
| 3080F | 0% | 76 | $0.00 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 52 | $0.00 |
| 3048F | 0% | 29 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 20,430 | $0.00 |
| 3078F | 0% | 9,185 | $0.00 | |
| 99072 | 0% | 4,940 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 10,761 | $0.00 |
| 3077F | 0% | 116 | $0.00 | |
| 3051F | 0% | 14 | $0.00 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 0% | 34 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRAQUIB, FAROUK (PHYSICIAN)
| Provider | Location | Paid |
|---|---|---|
| Med 360 Urgent Care, LLC | Jasper, AL | $1.52M |
| Med 360 Urgent Care Northport LLC | Northport, AL | $785K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.